With box warnings

Without box warnings

Branded

Generic

2 results

tibsovo
(ivosidenib)
Servier Pharmaceutical LLC
Usage: TIBSOVO is indicated for treating newly diagnosed acute myeloid leukemia (AML) with an IDH1 mutation, relapsed or refractory AML, relapsed or refractory myelodysplastic syndromes (MDS), and previously treated locally advanced or metastatic cholangiocarcinoma with an IDH1 mutation in adults.
voranigo
(vorasidenib)
Servier Pharmaceuticals LLC
Usage: VORANIGO is indicated for treating adults and pediatric patients aged 12 and older with Grade 2 astrocytoma or oligodendroglioma harboring IDH1 or IDH2 mutations, post-surgery (biopsy, sub-total, or gross total resection), as identified by an FDA-approved test.

Isocitrate Dehydrogenase 1 Inhibitor class drugs

tibsovo